- Home
- OPK vs TXO Comparison
OPK vs TXO Comparison
Compare OPK & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- TXO
- Stock Information
- Founded
- OPK 2007
- TXO 2012
- Country
- OPK United States
- TXO United States
- Employees
- OPK N/A
- TXO N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- TXO Oil & Gas Production
- Sector
- OPK Health Care
- TXO Energy
- Exchange
- OPK Nasdaq
- TXO Nasdaq
- Market Cap
- OPK 1.0B
- TXO 788.9M
- IPO Year
- OPK 1995
- TXO 2023
- Fundamental
- Price
- OPK $1.40
- TXO $13.85
- Analyst Decision
- OPK Buy
- TXO Strong Buy
- Analyst Count
- OPK 4
- TXO 2
- Target Price
- OPK $2.75
- TXO $21.50
- AVG Volume (30 Days)
- OPK 1.9M
- TXO 173.7K
- Earning Date
- OPK 11-06-2025
- TXO 11-04-2025
- Dividend Yield
- OPK N/A
- TXO 17.39%
- EPS Growth
- OPK N/A
- TXO N/A
- EPS
- OPK N/A
- TXO 0.30
- Revenue
- OPK $664,029,000.00
- TXO $332,267,000.00
- Revenue This Year
- OPK N/A
- TXO $31.08
- Revenue Next Year
- OPK $0.84
- TXO $11.32
- P/E Ratio
- OPK N/A
- TXO $46.62
- Revenue Growth
- OPK N/A
- TXO 15.94
- 52 Week Low
- OPK $1.11
- TXO $13.28
- 52 Week High
- OPK $2.04
- TXO $20.70
- Technical
- Relative Strength Index (RSI)
- OPK 53.59
- TXO 44.25
- Support Level
- OPK $1.34
- TXO $13.42
- Resistance Level
- OPK $1.44
- TXO $13.88
- Average True Range (ATR)
- OPK 0.04
- TXO 0.27
- MACD
- OPK 0.00
- TXO 0.03
- Stochastic Oscillator
- OPK 60.00
- TXO 62.16
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.